These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 7758989)

  • 1. Effect of alpha IFN on unaggressive immunoproliferative disorders.
    Frigeri F; De Renzo A; Marcenò R; Ruggeri P; Musto P; Andriani A; Citarrella P; Caronia F; Rotoli B
    Haematologica; 1995; 80(1):35-9. PubMed ID: 7758989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adherence and mental side effects during hepatitis C treatment with interferon alfa and ribavirin in psychiatric risk groups.
    Schaefer M; Schmidt F; Folwaczny C; Lorenz R; Martin G; Schindlbeck N; Heldwein W; Soyka M; Grunze H; Koenig A; Loeschke K
    Hepatology; 2003 Feb; 37(2):443-51. PubMed ID: 12540795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Interferon-alpha in the treatment of myeloproliferative syndromes].
    Ballarino P; Castello G; Lerza R
    Recenti Prog Med; 1994 Nov; 85(11):546-50. PubMed ID: 7855389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Various immunoproliferative disorders].
    Shimazaki C; Goto H; Nakagawa M
    Nihon Naika Gakkai Zasshi; 1995 Jul; 84(7):1107-11. PubMed ID: 7561367
    [No Abstract]   [Full Text] [Related]  

  • 5. Free interferon-alpha/beta receptors in the circulation of patients with adenocarcinoma.
    Ambrus JL; Dembinski W; Ambrus JL; Sykes DE; Akhter S; Kulaylat MN; Islam A; Chadha KC
    Cancer; 2003 Dec; 98(12):2730-3. PubMed ID: 14669296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective comparison of four lymphoblastoid interferon alpha schedules for chronic hepatitis C. A multivariate analysis of factors predictive of sustained response to treatment.
    Bellobuono A; Mondazzi L; Tempini S; Silini E; Idéo G
    Eur J Gastroenterol Hepatol; 1997 Dec; 9(12):1169-77. PubMed ID: 9471022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prior treatment with alpha-interferon does not adversely affect the outcome of allogeneic BMT in chronic phase chronic myeloid leukemia.
    Zuffa E; Bandini G; Bonini A; Santucci MA; Martinelli G; Rosti G; Testoni N; Zaccaria A; Tura S
    Haematologica; 1998 Mar; 83(3):231-6. PubMed ID: 9573677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multicenter prospective study of interferon-alpha and conventional chemotherapy versus bone marrow transplantation for newly diagnosed patients with chronic myelogenous leukemia. Kouseisho Leukemia Study Group.
    Ohnishi K; Minami S; Ueda T; Nishimura M; Tsubaki K; Takemoto Y; Takeshita A; Sao H; Kageyama S; Ueda R; Ohno R
    Int J Hematol; 2000 Aug; 72(2):229-36. PubMed ID: 11039674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allogeneic transplantation for hematological malignancies using rho G-CSF mobilized blood stem cells.
    Azevedo WM; Aranha FJ; Gouvea JV; Vigorito AC; Marques JF; Eid KA; Azevedo AM; Barbosa KB; Souza CA
    Bone Marrow Transplant; 1996 Mar; 17 Suppl 2():S54-5. PubMed ID: 8722337
    [No Abstract]   [Full Text] [Related]  

  • 10. Angiocentric immunoproliferative lesion of the lung.
    Ichiki Y; Osaki T; Yamashita T; Oyama T; Sugio K; Yasumoto K
    Jpn J Thorac Cardiovasc Surg; 2002 Aug; 50(8):353-5. PubMed ID: 12229222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is interferon-alpha therapy safe and effective for patients with chronic hepatitis C and inflammatory bowel disease? A case-control study.
    Bargiggia S; Thorburn D; Anderloni A; Ardizzone S; Giorgi A; Bianchi Porro G; Parente F
    Aliment Pharmacol Ther; 2005 Aug; 22(3):209-15. PubMed ID: 16091058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of oromucosally administered interferon-alpha in the prevention and treatment of animal diseases.
    Dec M; Puchalski A
    Pol J Vet Sci; 2008; 11(2):175-86. PubMed ID: 18683548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meta-analysis: interferon-alpha prevents the recurrence after curative treatment of hepatitis C virus-related hepatocellular carcinoma.
    Miyake Y; Takaki A; Iwasaki Y; Yamamoto K
    J Viral Hepat; 2010 Apr; 17(4):287-92. PubMed ID: 19732321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon-alpha as a treatment modality for colchicine- resistant familial Mediterranean fever.
    Tweezer-Zaks N; Rabinovich E; Lidar M; Livneh A
    J Rheumatol; 2008 Jul; 35(7):1362-5. PubMed ID: 18528960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aerosolized interferon-alpha treatment in patients with multi-drug-resistant pulmonary tuberculosis.
    Giosuè S; Casarini M; Ameglio F; Zangrilli P; Palla M; Altieri AM; Bisetti A
    Eur Cytokine Netw; 2000 Mar; 11(1):99-104. PubMed ID: 10705306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors influencing long-term changes in mental health after interferon-alpha treatment of chronic hepatitis C.
    Schmidt F; Janssen G; Martin G; Lorenz R; Loeschke K; Soyka M; Folwaczny C; Schaefer M
    Aliment Pharmacol Ther; 2009 Nov; 30(10):1049-59. PubMed ID: 19691667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longterm efficacy of interferon-alpha for extrahepatic disease associated with hepatitis C virus infection.
    Naarendorp M; Kallemuchikkal U; Nuovo GJ; Gorevic PD
    J Rheumatol; 2001 Nov; 28(11):2466-73. PubMed ID: 11708420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Our experience with interferon alpha: renal cell carcinoma.
    Merimsky O; Chaitchik S
    Mol Biother; 1992 Sep; 4(3):130-4. PubMed ID: 1445666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized clinical trial of the effect of interferon alpha on survival in patients with disseminated midgut carcinoid tumours.
    Kölby L; Persson G; Franzén S; Ahrén B
    Br J Surg; 2003 Jun; 90(6):687-93. PubMed ID: 12808615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of interferon-alpha in the management of myelomatosis.
    Avvisati G; Mandelli F
    Hematol Oncol Clin North Am; 1992 Apr; 6(2):395-405. PubMed ID: 1582981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.